Anja Hohmann

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

Laetitia J. Martin, Manfred Koegl, Gerd Bader et al. · Journal of Medicinal Chemistry · 2016 · 219 citations · Full text

Molecular Biology, Cancer Biology, Tumor Biology +17

Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition

Anja Hohmann, Laetitia J. Martin, Jessica L. Minder et al. · Nature Chemical Biology · 2016 · 174 citations · Full text

Hematological Malignancy, Novel Therapy, Myeloid Leukemia Cells +5

BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements

Anand Bhagwat, Jae‐Seok Roe, Beverly Y.L. Mok et al. · Cell Reports · 2016 · 157 citations · Full text

The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer

Eric Wang, Shinpei Kawaoka, Jae‐Seok Roe et al. · eLife · 2015 · 49 citations · Full text

Single Enhancer, Mixed-phenotype Acute Leukemia, Genetics +21

Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens

Michael R. Schlabach, Sharon Lin, Zachary R. Collester et al. · Journal of Clinical Investigation · 2023 · 30 citations · Full text

Cancer Immunosurveillance, Crispr/cas9 Screens, Comprehensive Crispr +15